Rituximab before splenectomy in adults with primary idiopathic thrombocytopenic purpura: a meta-analysis
Author:
Affiliation:
1. Haematology Department; University Hospital Saint-Eloi; Montpellier; France
2. Biostatistical Unit; University of Medicine; Inserm EA 2415; Montpellier; France
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2012.09169.x/fullpdf
Reference45 articles.
1. Rituximab in the treatment of idiopathic thrombocytopenic purpura (ITP);Alasfoor;Annals of Hematology,2009
2. Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura;Arnold;Annals of Internal Medicine,2007
3. Treatment of immune thrombocytopenia: a retrospective study of 40 patients;Audia;La Revue De Médecine Interne,2010
4. Efficacy of early use of rituximab in steroid refractory severe immune thrombocytopenic purpura in adult patients: single institution experience from Saudi Arabia;Badar;Blood (ASH Annual Meeting Abstracts),2010
5. Monoclonal antibodies and progressive multifocal leukoencephalopathy;Berger;mAbs,2009
Cited by 75 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Zuberitamab, an innovative anti-CD20 monoclonal antibody, for patients with primary immune thrombocytopenia in China: a randomized, double-blind, placebo-controlled, phase 2 study;The Lancet Regional Health - Western Pacific;2024-06
2. Rituximab versus Splenectomy in Chronic Primary ITP: Experience of a Single Hematology Clinic;Mediterranean Journal of Hematology and Infectious Diseases;2024-02-29
3. Markers of refractory primary immune thrombocytopenia;British Journal of Haematology;2023-08-30
4. Bisphosphonate use for glucocorticoid-induced osteoporosis in older patients with immune thrombocytopenia: a clinical perspective;Annals of Hematology;2023-05-12
5. Current approaches for the diagnosis and management of immune thrombocytopenia;European Journal of Internal Medicine;2023-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3